The head of Moscow’s Gamaleya National Center of Epidemiology and Microbiology, which created the Sputnik V Covid-19 vaccine, and the boss of the fund that bankrolled its development, have spoken to RT about a fresh study that has found the jab to be much more effective against the Omicron variant than the German-American Pfizer formula.
A comparative Italian-Russian paper, published earlier this week, revealed that Sputnik V was 2.6 times better in tackling Omicron than the popular Western alternative.
Sputnik V has shown a more-than-eightfold reduction of virus-neutralizing activity against the new super-mutant coronavirus strain, in contrast to a 21.4-fold drop for the Pfizer vaccine, according to the study by Italy’s Lazzaro Spallanzani National Institute for Infectious Diseases and the aforementioned Gamaleya Center. The paper also said Sputnik Light, a one-shot version of the product, provided significantly increased virus-neutralizing activity against Omicron when used as a booster.
Moscow will retaliate against British targets in Ukraine or elsewhere if Kiev uses UK-provided missiles…
Ukrainian President Vladimir Zelensky cannot enlist God in Kiev’s fight against Moscow, the Russian Orthodox…
Ukrainian President Vladimir Zelensky has proclaimed that God is an “ally” of Ukraine in the…
Israel is willing to pause its military offensive in Gaza if Hamas releases all the…
The EU’s top diplomat, Josep Borrell, has admitted that not every member state agrees to…
Russia’s Defense Ministry has published a video clip from the front line with Ukraine showing…